Sienna Biopharmaceuticals, Inc. Operating Expenses
Sienna Biopharmaceuticals, Inc. reported Operating Expenses of $6.04 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-11-12
- Sienna Biopharmaceuticals, Inc. operating expenses for the quarter ending 2019-09-30 was $6.04M, a 63.60% decline year-over-year.
- Sienna Biopharmaceuticals, Inc. operating expenses for the quarter ending 2019-06-30 was $7.73M, a 64.34% decline year-over-year.
- Sienna Biopharmaceuticals, Inc. operating expenses for the quarter ending 2019-03-31 was $15.84M, a 14.28% decline year-over-year.
- Sienna Biopharmaceuticals, Inc. operating expenses for the quarter ending 2018-12-31 was $19.77M, a 41.31% increase year-over-year.
- Sienna Biopharmaceuticals, Inc. operating expenses for fiscal 2018 was $76.50M, a 57.50% increase from fiscal 2017.
- Sienna Biopharmaceuticals, Inc. operating expenses for fiscal 2017 was $48.57M, a 134.77% increase from fiscal 2016.
- Sienna Biopharmaceuticals, Inc. operating expenses for fiscal 2016 was $20.69M, a 86.22% increase from fiscal 2015.
- Sienna Biopharmaceuticals, Inc. operating expenses for fiscal 2015 was $11.11M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2019-09-30 | $6.04M 10-Q · filed 2019-11-12 | $13.76M derived: sum of 2 quarters · filed 2019-11-12 | $29.60M 10-Q · filed 2019-11-12 | $49.37M derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | $7.73M 10-Q · filed 2019-08-08 | $23.57M 10-Q · filed 2019-08-08 | $43.34M derived: sum of 3 quarters · filed 2019-08-08 | $59.92M derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | $15.84M 10-Q · filed 2019-05-08 | $35.61M derived: sum of 2 quarters · filed 2019-05-08 | $52.19M derived: sum of 3 quarters · filed 2019-05-08 | $73.86M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-12-31 | $19.77M 10-K · filed 2019-03-14 | $36.35M derived: sum of 2 quarters · filed 2019-03-14 | $58.02M derived: sum of 3 quarters · filed 2019-08-08 | $76.50M 10-K · filed 2019-03-14 |
| 2018-09-30 | $16.58M 10-Q · filed 2019-11-12 | $38.25M derived: sum of 2 quarters · filed 2019-08-08 | $56.73M 10-Q · filed 2019-11-12 | $70.72M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-06-30 | $21.67M 10-Q · filed 2019-08-08 | $40.15M 10-Q · filed 2019-08-08 | $54.13M derived: sum of 3 quarters · filed 2019-08-08 | $68.46M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $18.48M 10-Q · filed 2019-05-08 | $32.47M derived: sum of 2 quarters · filed 2019-05-08 | $46.79M derived: sum of 3 quarters · filed 2019-05-08 | $58.05M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $13.99M 10-K · filed 2019-03-14 | $28.31M derived: sum of 2 quarters · filed 2019-03-14 | $39.58M derived: sum of 3 quarters · filed 2019-03-14 | $48.57M 10-K · filed 2019-03-14 |
| 2017-09-30 | $14.32M 10-K · filed 2019-03-14 | $25.59M derived: sum of 2 quarters · filed 2019-03-14 | $34.58M 10-Q · filed 2018-11-08 | $41.98M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | $11.27M 10-K · filed 2019-03-14 | $20.26M 10-Q · filed 2018-08-09 | $27.66M derived: sum of 3 quarters · filed 2019-03-14 | $31.99M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-03-31 | $8.99M 10-K · filed 2019-03-14 | $16.39M derived: sum of 2 quarters · filed 2019-03-14 | $20.72M derived: sum of 3 quarters · filed 2019-03-14 | $25.75M derived: sum of 4 quarters · filed 2019-03-14 |
| 2016-12-31 | $7.40M 10-K · filed 2018-03-15 | $11.73M derived: sum of 2 quarters · filed 2018-03-15 | $16.76M derived: sum of 3 quarters · filed 2018-03-15 | $20.69M 10-K · filed 2019-03-14 |
| 2016-09-30 | $4.33M 10-K · filed 2018-03-15 | $9.36M derived: sum of 2 quarters · filed 2018-03-15 | $13.29M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $5.03M 10-K · filed 2018-03-15 | $8.96M 10-Q · filed 2017-09-07 | ||
| 2016-03-31 | $3.93M 10-K · filed 2018-03-15 | |||
| 2015-12-31 | $11.11M 10-K · filed 2018-03-15 |